The objective of establishing this centralized laboratory facility is to make the best use of the Center's resources and to avid redundance in equipment and personnel. In this core unit, we propose to establish two independent laboratories. They are a Protein Analysis Laboratory and Histology Laboratory. The major responsibility of this centralized core facility is to provide technical service and support to four proposed research projects. Since all procedures in these laboratories require precision and repetitive manipulations, they can be best carried out by centralized and experienced personnel. The Protein Analysis Laboratory will include analysis of complex protein mixtures from specimens by high- pressure liquid chromatography (HPLC) and two-dimensional gel electrophoresis (2-D). The HPLC will be used to separate complex mixtures of proteins into fractions of biologically active proteins for further analysis. 2-D electrophoresis will include the ISO-DALT System to separate proteins by isoelectric points in the first dimension and molecular weights in the second dimension. In addition to silver-staining to visualize the protein spots, the techniques of Western blotting and fluorography will be used. A computer-based image analysis system will also be used in qualitative and quantitative assessment of the resulting two-dimensional protein profiles. It is anticipated that approximately 400 gels will be processed by this laboratory each year (100 gels for each project). this capacity represents half of the operating capacity of the laboratory. The Histology Laboratory will be responsible for processing of all specimens generated by the four research projects for light microscopy. Besides the routine H&E sections, the laboratory will conduct immunohistochemistry, autoradiography, and quantitative analysis by a computer-based image analysis system.

Project Start
1996-08-01
Project End
1999-07-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
10
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Type
DUNS #
City
Evanston
State
IL
Country
United States
Zip Code
60201
Ilio, K Y; Nemeth, J A; Sensibar, J A et al. (2000) Prostatic ductal system in rats: changes in regional distribution of extracellular matrix proteins during castration-induced regression. Prostate 43:10-Mar
Kassen, A E; Sensibar, J A; Sintich, S M et al. (2000) Autocrine effect of DHT on FGF signaling and cell proliferation in LNCaP cells: role of heparin/heparan-degrading enzymes. Prostate 44:124-32
Lee, C; Sintich, S M; Mathews, E P et al. (1999) Transforming growth factor-beta in benign and malignant prostate. Prostate 39:285-90
Sensibar, J A; Pruden, S J; Kasjanski, R Z et al. (1999) Differential growth rates in stromal cultures of human prostate derived from patients of varying ages. Prostate 38:110-7
Kim, I Y; Zelner, D J; Lee, C (1998) The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP. Exp Cell Res 241:151-60
Grayhack, J T; Kozlowski, J M; Lee, C (1998) The pathogenesis of benign prostatic hyperplasia: a proposed hypothesis and critical evaluation. J Urol 160:2375-80
Sherwood, E R; Van Dongen, J L; Wood, C G et al. (1998) Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells. Br J Cancer 77:855-61
Grayhack, J T; Sensibar, J A; Ilio, K Y et al. (1998) Synergistic action of steroids and spermatocele fluid on in vitro proliferation of prostate stroma. J Urol 159:2202-9
Kim, I Y; Ahn, H J; Lang, S et al. (1998) Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer patients. Clin Cancer Res 4:1625-30
Gann, P H; Chatterton, R; Vogelsong, K et al. (1997) Epidermal growth factor-related peptides in human prostatic fluid: sources of variability in assay results. Prostate 32:234-40

Showing the most recent 10 out of 59 publications